Kanwaljit Singh, MD, MPH

Kanwaljit Singh, MD, MPH is the Executive Director of C-Path’s International Neonatal Consortium (INC) and Director of Pediatric Programs in Tucson, Arizona. Dr. Singh comes to C-Path from University of Massachusetts Medical School (UMass), Worcester, MA, where he worked for more than seven years as Instructor of Pediatric Neurology. At UMass, Dr. Singh’s research focused on evaluating novel treatment options for Autism Spectrum Disorders (ASD) and evaluating the safety and efficacy of a small molecule (Sulforaphane) present in broccoli sprouts in the treatment of ASD. Dr. Singh has also done extensive research and has numerous publications in pediatric epilepsy. Before UMass, he worked in ASD research at Lurie Center for Autism at Massachusetts General Hospital/Harvard Medical School in Boston. In addition to his research work, Dr. Singh also served on the IRB committees at Harvard Medical School and interacted with regulatory authorities, including the FDA. His experience also includes the testing of medical devices in hypertension and diabetes mellitus.